Oncology
Choice of radiation dose
This is an English translation of the danish ”Valg af stråledosis” patient decision aid. Concerns patients planned to receive high dose stereotactic body radiation therapy for a tumor In the lung located less than 1 cm from the thoracic wall. The patients will be able to choose either high or lower radiation dose. A lower dose will decrease the risk of side effects, but local tumor control might also be decreased. The Danish patient decision aid is being tested in a local randomized trial, SDM Lung SBRT
Diagnosis
Lung cancer or lung metastasis from another primary cancer
Subject area
Treatment
Options
- High dose, 66 Gray in 3 fractions
- Lower dose, 45 Gray in 3 fractions
Preparation sheet included
No
Developed by
Department of Oncology, Lillebaelt Hospital, Vejle in collaboration with CFFB
Responsible for update
Physician, PhD-student Thomas Leth Fink, Department of Oncology, Lillebaelt Hospital, Vejle
Version
1
Date
2022
Scheduled update
November 2022
Access to DECISION HELPERTM
For any further questions, please contact Centre for Shared Decision Making.
Users logged into a regional network can access the draft decision aid (pdf)
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
Six of six qualifying criteria are met
This Patient Decision Aid meets the IPDAS qualifying criteria to be defined as a Patient Decision Aid
Five of Five certifying criteria are met
Certifying criteria lower the risk of making a biased decision
Fourteen of seventeen quality criteria are met
Quality criteria that strengthen the quality of the Patient Decision Aid
Only applicable criteria are included in the assessment